Eolas Medical has raised $12 million (£8.9m) in a Series A round led by Acton Capital, as it looks to scale AI in the NHS.
The Belfast-based business will also look to scale its point-of-care knowledge platform as it expands internationally.
The clinician-led HealthTech is already used across 400+ UK clinical sites and in 85% of NHS acute trusts, helping frontline teams access local guidance, policies and medicines information “up to 10 times faster” than traditional intranets and document systems.
It ranked 21st in BusinessCloud’s HealthTech 50 for 2025 and was born out of its founder’s frustrations.
“Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it,” said Dr Declan Kelly, founder and CEO of Eolas Medical.
“This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely – particularly in the winter.”
“As AI develops, the next phase is about making that access even more usable, so staff can ask a question and get a clear, evidence-backed answer straight away, in plain language.
“We’re delighted that our investor partners recognise the importance of our bespoke AI knowledge tool, so we can build on what’s already working across the NHS and support organisations as pressure builds on services and care continues to move beyond traditional hospital settings.”
The company said demand for consistent clinical guidance is increasing as NHS services come under pressure, staff rotate between trusts and care continues to shift beyond hospital settings.
Its latest AI-powered search feature allows clinicians to ask questions in plain English and receive answers sourced directly from their organisation’s approved internal resources.
Acton Capital managing partner, Fritz Oidtmann, added: “Our conversations with clinicians showed remarkable enthusiasm for Eolas. Clinicians love the product.
“The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical.”